Literature DB >> 10833324

A behavioral test paradigm to measure the aversive quality of inflammatory and neuropathic pain in rats.

C J LaBuda1, P N Fuchs.   

Abstract

The present experiment assessed the aversive quality of neuropathic and inflammatory pain in rats. Compared to sham-treated animals, L5 ligated (neuropathic) and complete Freund's adjuvant (inflammatory)-treated animals displayed an initial period of escape followed by avoidance of a preferred location of the test chamber that was associated with mechanical stimulation of the hyperalgesic paw. The onset of the avoidance behavior occurred during the first 10-15 min of behavioral testing and was maximal at 30 min. It is concluded that animals find mechanical stimulation of the hyperalgesic paw aversive and that this behavioral test paradigm is an additional method that may be used to assess nociception in rat neuropathic and inflammatory models. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10833324     DOI: 10.1006/exnr.2000.7395

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  70 in total

Review 1.  Behavioral assessments of the aversive quality of pain in animals.

Authors:  Xu-Jie Zhang; Tian-Wei Zhang; San-Jue Hu; Hui Xu
Journal:  Neurosci Bull       Date:  2011-02       Impact factor: 5.203

2.  Conditioned place preference reveals tonic pain in an animal model of central pain.

Authors:  Leyla Davoody; Raimi L Quiton; Jessica M Lucas; Yadong Ji; Asaf Keller; Radi Masri
Journal:  J Pain       Date:  2011-04-23       Impact factor: 5.820

3.  DAMGO in the central amygdala alleviates the affective dimension of pain in a rat model of inflammatory hyperalgesia.

Authors:  R-X Zhang; M Zhang; A Li; L Pan; B M Berman; K Ren; L Lao
Journal:  Neuroscience       Date:  2013-08-28       Impact factor: 3.590

Review 4.  Neuropathic Pain After Spinal Cord Injury: Challenges and Research Perspectives.

Authors:  Rani Shiao; Corinne A Lee-Kubli
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

5.  The role of alpha5 nicotinic acetylcholine receptors in mouse models of chronic inflammatory and neuropathic pain.

Authors:  Deniz Bagdas; Shakir D AlSharari; Kelen Freitas; Matthew Tracy; M Imad Damaj
Journal:  Biochem Pharmacol       Date:  2015-04-28       Impact factor: 5.858

6.  Antihyperalgesic effects of imidazoline I(2) receptor ligands in rat models of inflammatory and neuropathic pain.

Authors:  Jun-Xu Li; David A Thorn; Yanyan Qiu; Bi-Wen Peng; Yanan Zhang
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

7.  The analgesic-like properties of the alpha7 nAChR silent agonist NS6740 is associated with non-conducting conformations of the receptor.

Authors:  Roger L Papke; Deniz Bagdas; Abhijit R Kulkarni; Timothy Gould; Shakir D AlSharari; Ganesh A Thakur; M Imad Damaj
Journal:  Neuropharmacology       Date:  2014-12-11       Impact factor: 5.250

Review 8.  Evaluation of reward from pain relief.

Authors:  Edita Navratilova; Jennifer Yanhua Xie; Tamara King; Frank Porreca
Journal:  Ann N Y Acad Sci       Date:  2013-03-15       Impact factor: 5.691

9.  The Antinociceptive and Antiinflammatory Properties of 3-furan-2-yl-N-p-tolyl-acrylamide, a Positive Allosteric Modulator of α7 Nicotinic Acetylcholine Receptors in Mice.

Authors:  Deniz Bagdas; Katarzyna M Targowska-Duda; Jhon J López; Edwin G Perez; Hugo R Arias; M Imad Damaj
Journal:  Anesth Analg       Date:  2015-11       Impact factor: 5.108

10.  Enhancing m currents: a way out for neuropathic pain?

Authors:  Ivan Rivera-Arconada; Carolina Roza; Jose A Lopez-Garcia
Journal:  Front Mol Neurosci       Date:  2009-08-04       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.